Pediatric Thyroidectomy: Surgical Extension Does Not Affect Survival
Topic overview
Retrospective analysis of 326 matched pediatric patients with early-stage papillary thyroid cancer shows no survival difference between total thyroidectomy and thyroid lobectomy. Findings challenge current aggressive treatment guidelines and suggest lobectomy may be adequate for low-risk disease, avoiding lifelong hormone replacement.
Key takeaways
- Total thyroidectomy does not improve survival vs lobectomy in pediatric PTC <4cm (median 5-8 year follow-up, propensity-matched cohorts).
- Thyroid lobectomy may be adequate for early-stage pediatric PTC, avoiding lifelong thyroid hormone replacement without compromising outcomes.
- Current guidelines recommending total thyroidectomy + radioablation for most pediatric PTC may be overly aggressive for localized disease.
- No significant difference in overall or disease-specific survival between surgical approaches in 326 matched pediatric patients (age ≤18).
Comments